Kim's Eye Hospital

Running trials

• Not yet recruiting

  Long Term Efficacy of Faricimab Using a Treat and Extend Regimen for Type 3 Macular Neovascularization

  NCT07187804· Phase 4· Kim's Eye Hospital· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Macular degeneration1 recruiting

Closed trials

• Completed

  A Trial to Evaluate the Safety and Usability of the SB15 PFS in Trial Participants With AMD, Macular Oedema Secondary to RVO, or Diabetic Macular Oedema

  NCT07844343· Phase 2· Samsung Bioepis Co., Ltd.· Source

• Completed

  Switching to Aflibercept 8mg in Patients Showing Limited Response to Previous Treatment

  NCT06683950· Phase 4· Kim's Eye Hospital· Source

• Completed

  A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema

  NCT05151731· Phase 2· Hoffmann-La Roche· Source

• Completed

  A Study to Investigate Vamikibart (RO7200220) in Combination With Ranibizumab in Diabetic Macular Edema

  NCT05151744· Phase 2· Hoffmann-La Roche· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Macular degeneration13 works · 3 trials